Key result
Subcutaneous implantable cardioverter defibrillators are a safe and effective alternative to transvenous ICDs for the prevention of sudden cardiac death.
Why the study?
Is the subcutaneous implantable cardioverter defibrillator safe and effective for the prevention of sudden cardiac death?
Is the subcutaneous implantable cardioverter defibrillator safe and effective for the prevention of sudden cardiac death?
Answers are grounded in this paper and cite their sources.
The S-ICD is a safe and effective alternative to transvenous ICDs for preventing sudden cardiac death across various patient populations.
The subcutaneous implantable cardioverter defibrillators (SICD) is an alternative to the transvenous ICD for the prevention of sudden cardiac death (SCD). Multiple studies have shown that the SICD is safe and effective in treating ventricular arrhythmias. While earlier studies mainly enrolled younger patients with channelopathies, more recent reports included patients with "typical" indications for ICD therapy for the prevention of SCD. In this review we summarize the data available to date on the SICD while highlighting its pros and cons.
No takes yet. Share an insight, caveat, or question.
Westerman et al. (2018) conducted a review in Prevention of sudden cardiac death (SCD). Subcutaneous implantable cardioverter defibrillators (SICD) vs. Transvenous ICD was evaluated. Subcutaneous implantable cardioverter defibrillators are a safe and effective alternative to transvenous ICDs for the prevention of sudden cardiac death.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: